Peptide Catalog Peptides

1-2 mg per week · Once per week

100-200 mcg per injection · 2-3 times daily

100-300 mcg per injection · 2-3 times per day

100-300 mcg per injection · 2-3 times per day

200-300 mcg per injection · 2-3 times per day

200-300 mcg per injection · 2-3 times daily

10-25 mg per dose · Once daily

200-500 mcg per injection · Once daily

1-2 mg per injection · Once daily

2-4 mg per injection · Once daily

250-500 mcg per injection · 1-2 times daily

1-2 capsules orally (0.2 g per capsule, containing AKS-4 peptide complex) · 1-2 times daily, with meals

1-3 mg per injection · Once daily or every other day

50-200 mcg per injection · Once daily

200-400 mcg per injection · Once daily (MGF) or 2-3 times per week (PEG-MGF)

2-5 mg per injection · Twice per week

50 mg per capsule · 1-2 times daily

0.03 mg/kg body weight (Phase 1 trial starting dose) · Once daily

0.1 mg/kg/min by intravenous infusion (CABG trial dose) · Single continuous infusion

300-600 mcg per injection · Once daily

1.2-4.5 mg per week (subcutaneous) · Once weekly

0.75-4.5 mg per week (subcutaneous) · Once weekly

5-10 mcg per injection (subcutaneous) · Twice daily (Byetta) or once weekly (Bydureon)

1.0-1.2 pmol/kg/min by intravenous infusion (research use) · Continuous infusion in a single session

0.5-1 mg per injection (hypoglycemic emergency); research doses vary · Single dose in emergency; as per protocol in research

250-500 mcg per injection · 1-2 times per day

20-50 mcg per injection · Once daily (training days)

12-36 mg per day (oral) · Once daily

15-120 mcg per injection (subcutaneous) · Before main meals (2-3 times daily)

0.5-12 mg per week (subcutaneous) · Once per week

0.25-2.4 mg per week (subcutaneous) · Once per week

1-3 mg per day (subcutaneous) · Once daily

2.5-15 mg per week (subcutaneous) · Once per week

100-500 mcg via intranasal or subcutaneous · 1-2 times daily

5-30 ml per injection · Once daily

100-300 mcg per subcutaneous injection · Once daily

1-5 mg per subcutaneous injection (some protocols use 5-10 mg per full cycle) · Once daily or every other day

25-200 mg intranasal (single ascending dose Phase 1) · Single dose (tolerability study)

1-2 capsules orally (0.2 g per capsule, containing AKS-5 peptide complex) · 1-2 times daily, with meals

250-500 mcg per injection · 1-2 times daily

300-600 mcg per injection · 1-2 times daily

5-20 IU or 1-4 mcg/kg · As clinically needed

0.25-3 mg per injection · Once daily (0.25 mg) or single dose (3 mg)

100-200 mcg per injection · 2-3 times per week

250-500 IU per injection · 2-3 times per week

1-10 mcg per injection · Per research protocol

0.5-2 mg per injection · Once daily or every other day

10-40 IU intranasal or 50-200 mcg subcutaneous · 1-2 times daily

500-2000 mcg per injection · As needed, maximum 2-3x/week

2 capsules orally (0.2-0.275 g per capsule, containing AKS-S peptide complex) · 1-2 times daily, before meals

100 mcg per injection · Once every 3-4 weeks

Topical 3-5% · Twice daily

Topical or 200-500 mcg subcutaneous · 1-2 times daily (topical), every other day (subcutaneous)

Topical 5-10% or 100-250 mcg subcutaneous · Topical twice daily, subcutaneous 2-3x per week

Topical application · 1-2 times daily

Topical or 200-600 mcg subcutaneous · 1-2 times daily (topical), every other day (subcutaneous)

Topical application · 1-2 times daily

0.5-1 mg per injection · Every other day (loading phase), weekly (maintenance)

250-500 mcg per injection · 3-7 times per week

Topical application · 1-2 times daily

Topical 3-10% or 100-500 mcg subcutaneous · Topical 2x daily, subcutaneous 2-3x per week

Topical application · 1-2 times daily

50-150 mcg per administration (IV or subcutaneous) · 1-3 times daily per protocol

1-2 capsules orally (0.2 g per capsule, containing AKS-B peptide complex) · 1-2 times daily, with meals

1-2 capsules orally (0.2 g per capsule, containing bronchial tissue peptide complex) · 1-2 times daily, with meals

1-2 capsules orally (0.2 g per capsule, containing AKS-6 peptide complex) · 1-2 times daily, before meals

1-2 mg per injection (subcutaneous or intramuscular) · 1-2 times daily

1-5 mcg/kg (research only) · Single dose or per research protocol

100-200 mcg per injection · Once daily

100-200 mcg per injection · Once daily

200-600 mg IV or 100-500 mg subcutaneous · 1-3 times per week

500-1000 mcg per injection · 1-2 times daily

72-290 mcg oral (subcutaneous research 100-500 mcg) · Once daily (oral)

3-6 mg per week (typically) · Once per week

1-5 mg per subcutaneous injection (or equivalent oral dose in the Amidate version) · Once daily or every other day

50-250 mg per injection · 2-3 times per week

1-2 capsules orally (0.2 g per capsule, containing hepato/gastrointestinal peptide complex) · 1-2 times daily, with meals

1-2 capsules orally (0.2 g per capsule, containing AKS-P peptide complex) · 1-2 times daily, before meals

Variable dosage per research · Per protocol

5-20 mg per intramuscular injection · Once daily

1.6 mg per injection · Twice per week

1-2 capsules orally (0.2 g per capsule, containing AKS-M peptide complex) · 1-2 times daily, with meals

1-2 capsules orally (0.2 g per capsule, containing AKS-2 peptide complex) · 1-2 times daily, with meals

200 mcg per day inhaled (4 inhalations of 50 mcg) · 4 times daily